Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This phase I/II trial studies the effect of sonoporation in addition to standard of care
chemotherapy in treating patients with pancreatic cancer. Sonoporation is a novel method that
uses ultrasound and microbubbles to increase therapeutic effect by increasing uptake or
enhance sensitization. Sonoporation together with chemotherapy may work better in treating
patients with pancreatic cancer compared to chemotherapy alone.